A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects

Autor:	Yang, Xin-Mei, Yang, Yang, Yao, Bu-Fan, Ye, Pan-Pan, Xu, Yan, Peng, Shao-Ping, Yang, Yu-Mei, Shu, Pan, Li, Pei-Jin, Li, Shan, Hu, Hong-Lin, Li, Qian, Song, Lin-Lin, Chen, Ke-Guang, Zhou, Hai-Yan, Zhang, Ye-Hui, Zhao, Fu-Rong, Tang, Bo-Hao, Zhang, Wei, Zhang, Xin-Fang, Fu, Shu-Meng, Hao, Guo-Xiang, Zheng, Yi, Shen, Jing-Shan, Xu, Ye-Chun, Jiang, Xiang-Rui, Zhang, Lei-Ke, Tang, Ren-Hong, Zhao, Wei
Zdroj:	In European Journal of Pharmaceutical Sciences 1 December 2023 191
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect